Centre for Research-based Innovation (SFI) status awarded to "Centre of Cardiological Innovation"
The project involves several Oslo Medtech members; the host Oslo University Hospital has Simula Research Laboratory as research partner and GE Vingmed Ultrasound AS, CardioSolv LLC, Biosense Webster Ltd and Kalkulo AS as company partners.
The Centre for Cardiological Innovation aims to be a world leader in research on ultrasound-based diagnosis.
The same time the research will generate considerable financial gain for the participating companies.
The seven new centres will each receive up to NOK 10 million a year for a period of up to eight years. This means an added investment in research-based innovation of up to NOK 560 million. In total the allocations from the Research Council to the centres will now amount to over NOK 200 million a year.
The purpose of the Centres for Research-based Innovation (SFI) is to build up and strengthen Norwegian research groups that work in close collaboration with partners from innovative industry and innovative public enterprises. The objective is to support long-term research that promotes innovation and the competitiveness of Norwegian industry. The SFI scheme is administered by the Research Council's Division for Innovation.
"This investment in the Centres for Research-based Innovation (SFI) scheme indicates the high level of priority given by the Government and the Research Council to long-term research that strengthens trade and industry and that also meets fundamental social challenges" says Minister of Research and Higher Education Tora Aasland.
"The SFI centres ensure that our best research groups are working in close contact with companies from industry. One of the main tasks of the centres is training for doctoral students who are conducting research on issues relevant to industry’s needs. Long-term investment in knowledge-intensive companies will generate a more robust and competitive industrial sector" states Minister of Trade and Industry Trond Giske.
